We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Invokana MDL Hearing Set For Dec. 1; Janssen Concurs, Agrees With New Jersey Venue

(October 18, 2016, 1:36 PM EDT) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) on Oct. 14 scheduled arguments for the creation of an Invokana multidistrict litigation to take place Dec. 1 in North Carolina (In Re:  Invokana [Canagliflozin] Products Liability Litigation, MDL Docket No. 2750, JMPDL).

Defendant Janssen Pharmaceuticals Inc. on Oct. 12 said it agrees with some plaintiffs that at least 57 federal lawsuits alleging kidney failure or ketoacidosis from the diabetes drug should be centralized in an MDL.

(Brief available.  Document #28-161020-005B.)

In a response filed with...
To view the full article, register now.